IOL Chemicals & Pharmaceuticals Ltd

BSE
IOLCP •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or open an account for live prices.
Start SIP in IOL Chemicals & Pharmaceuticals Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
29.41% Gain from 52W Low
7.1
TTM PE Ratio
Below industry Median
18.7
Price to Book Ratio
Low in industry
1.6
Dividend yield 1yr %
Below industry Median
1.2
TTM PEG Ratio
PEG TTM is negative
-5.5
RSI
RSI is mid-range
59.8
MFI
MFI Overbought
79.1

IOL Chemicals & Pharmaceuticals Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

IOL Chemicals & Pharmaceuticals Ltd shareholding Pattern

Promoter
48.2%
Foreign Institutions
1.4%
Mutual Funds
0.1%
Domestic Institutions
0.3%
Public
50.1%
Promoter
48.2%
Foreign Institutions
2.2%
Mutual Funds
0.1%
Domestic Institutions
0.4%
Public
49.3%
Promoter
48.2%
Foreign Institutions
2.3%
Domestic Institutions
0.4%
Public
49.1%
Promoter
48.2%
Foreign Institutions
3.5%
Domestic Institutions
0.3%
Public
48%
Promoter
48.2%
Foreign Institutions
2.4%
Domestic Institutions
0.2%
Public
49.1%
Promoter
43.7%
Foreign Institutions
2.4%
Domestic Institutions
0.2%
Public
53.8%

IOL Chemicals & Pharmaceuticals Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
16
Bearish Moving Averages
0
5Day EMA
425.90
10Day EMA
423.40
12Day EMA
421.90
20Day EMA
415.10
26Day EMA
410.70
50Day EMA
401.40
100Day EMA
401.10
200Day EMA
405.60
5Day SMA
428.00
10Day SMA
426.30
20Day SMA
417.80
30Day SMA
401.30
50Day SMA
390.40
100Day SMA
391.60
150Day SMA
410.90
200Day SMA
420.20
Delivery & Volume
Resistance & Support
428.83
Pivot
Resistance
First Resistance
438.12
Second Resistance
448.08
Third Resistance
457.37
Support
First Support
418.87
Second support
409.58
Third Support
399.62
Relative Strength Index
59.83
Money Flow Index
79.14
MACD
11.20
MACD Signal
11.49
Average True Range
14.51
Average Directional Index
28.12
Rate of Change (21)
9.39
Rate of Change (125)
-8.37
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Amrutanjan Health Care Ltd.
2173.36
556.05
826
RPG Life Sciences Ltd.
2593.48
941.9
1740
Hester Biosciences Ltd.
2290.86
1292.9
2751
Dishman Carbogen Amcis Ltd.
2634.74
132.75
282.95
Solara Active Pharma Sciences Ltd.
2499.51
264.51
638.5
Jeena Sikho Lifecare Ltd.
-
-
-

IOL Chemicals & Pharmaceuticals Ltd Company background

Founded in: 1986
Managing director: Varinder Gupta
IOL Chemicals and Pharmaceuticals Ltd is a leading organic chemicals manufacturer and supplier in India. The company manufactures active pharmaceutical ingredient, organic chemicals and intermediates. The company was incorporated in the year 1986.The company manufactures and supplies industrial chemicals and bulk drugs for use in various pharmaceutical applications. Their portfolio includes industrial chemicals, industrial organic chemicals and bulk drugs.The company has two segments namely chemicals and pharmaceuticals. Under the chemical division, the company manufactures bulk chemicals, such as acetic acid and specialty chemicals, including ethyl acetate and acetic anhydride. Under pharmaceuticals division, the company manufactures active pharmaceutical ingredient, Ibuprofen.The company has two manufacturing units namely API Unit and Chemical Unit located in Punjab. API Unit manufactures Ibuprofen with the installed Capacity of 10 MTPD. Chemical Unit manufactures organic chemicals such as Glacial Acetic Acid, Ethyl Acetate, Acetic Anhydride, Mono chloro acetic Acid, Acetyl Chloride and Iso butyl Benzene. The company is having their presence in over 40 countries across the world, which includes Bangladesh, Thailand, UAE, Syria, Singapore, Hong Kong, Pakistan, Egypt, and many others. They have strong business relationships with a number of prestigious clients such as Ranbaxy Labs, Dr Reddy. DS Group, Cipla, Uflex Industries, ITC Ltd, ICI Paints, Asian Paints, Pidillte, Rallis India, Hindustan Polymide, Gujarat Super Phosphate and Avon Organics Ltd etc.The capacity enhancement project and Multi Product PPIs Plant and other pharmaceutical intermediate products with a CAPEX of Rs 130 crore was completed in 2012. The Company undertook another project of multi product plant for manufacture active pharmaceutical ingredients and upgrading of RD facilities involving a CAPEX of Rs 58.41 crore.G Drugs and Pharmaceuticals Limited (GDPL) was merged with Company, through The Board for Industrial and Financial Reconstruction (BIFR), vide its order dated 15 March 2012, with appointed date of 1 April 2010. The said Merger was made effective on 20 April 2012 and consequently GDPL ceased to exit from that date.During the current year 201617, the Company converted its existing multiple purpose plant into a dedicated ibuprofen manufacturing facility and resulting to its conversion, the ibuprofen manufacturing facility increased from 6200 TPA to 7200 TPA. During year 201718, Unit III to manufacture Fenofi brate, Clopidogrel and Lamotrigine Project was set up which costed Rs 16.48 crore. The company also setup Unit IV for manufacturing Metformin an antidiabetic drug with a capacity of 3000 MT per annum with project cost of Rs 10.02 crore. It enhanced installed capacity of Ibuprofen from 7200 TPA to 10000 TPA by debottlenecking and reengineering the plant in the month of August 2018.During year 2019, the Company has enhanced installed capacity of Metformin from 3,000 TPA to 4,000 TPA with a capex of Rs 2.71 crore it set up Unit V o manufacture Clopidogrel Bisulphate Fenofibrate with a capacity of 180 MT per annum with capex of Rs 19.26 crore it further enhanced existing manufacturing facilities of Ibuprofen from 10,000 TPA to 12,000 TPA and Iso Butyl Benzene from 9,000 TPA to 12,000 TPA in May 2019 with capex of Rs 12.10 crore. During 2020, the Company set up Unit VI, with an installed capacity of 240 MT per annum, which costed Rs 33.83 Crore, to manufacture Pantoprazole and has started its trial production. During 2021, the Company set up an another Unit7 for manufacturing Metformin with an additional capacity of 7,200 MT per annum for project costing Rs 28 cr. It installed new manufacturing facilities Unit8 to manufacture Ibuprofen Derivatives and other Pharma Products during FY 202021. It increased existing manufacturing facilities of Ethyl Acetate from 87,000 MT per annum to 100,000 MT per annum in Chemical segment during 202122.During the year 202223, IOL Foundation was incorporated as wholly owned subsidiary company. The Company set up multi product manufacturing facilities Unit 10 for manufacturing pharma APIs. It identified to manufacture Fenofibrate, Lamotrigine etc in this unit. Further, it also initiated the project for installation of new manufacturing facilities (Unit9) for manufacturing Gabapentin and other Pharma products during the year, which is under implementation.
Read More

IOL Chemicals & Pharmaceuticals Ltd FAQs

The past 1-year return of IOL Chemicals & Pharmaceuticals Ltd [IOLCP] share was 14.48. The IOL Chemicals & Pharmaceuticals Ltd [IOLCP] share hit a 1-year low of Rs. 333 and a 1-year high of Rs. 535.6.

The Mutual Fund Shareholding was 0.08% at the end of .

You can easily buy IOL Chemicals & Pharmaceuticals Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -